se of vaginal misoprostol with and without letrozole and combination of misoprostol and laminaria for preoperative cervical ripening
Phase 2
- Conditions
- Medical abortion.Medical abortion000-008
- Registration Number
- IRCT2016100923559N6
- Lead Sponsor
- Vice chancellor for research, Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Under 20 weeks pregnancy and fetal death. Exclusion criteria: Cesarean section history; adrenal diseases; asthma; history of thromboembolism
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fetus abortion. Timepoint: Eight hours after the intervention, and every twenty-four hours up to three days if the abortion doesn't occur. Method of measurement: Transvaginal Ultrasonography.
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: Every four hours until abortion occurs and at the time that abortion occurs. Method of measurement: Visual analog scale.